Epidemiology of Prostate Cancer

Prashanth Rawla

doi:10.14740/wjon1191

journal article Jan 01, 2019

Epidemiology of Prostate Cancer

Prashanth Rawla

World Journal of Oncology Vol. 10 No. 2 pp. 63-89 · Elmer Press, Inc.

View at Publisher Save 10.14740/wjon1191

Topics

No keywords indexed for this article. Browse by subject →

Cited By

2,285

Burden, clinical characteristics, and management patterns of prostate cancer in Nigeria: a systematic review and meta-analysis

Wusa Makena, Monday Nwankwo · 2026

Frontiers in Oncology

Evaluation Of Boron's Anticancer Effect

Seda Kuşoğlu Gültekin, Şeyma Yektar · 2026

Journal of Boron

Transforming Prostate Cancer Care: Innovations in Diagnosis, Treatment, and Future Directions

Sanaz Vakili, Iman Beheshti · 2025

International Journal of Molecular...

EpiSwitch PSE Blood Test Reduces Unnecessary Prostate Biopsies: A Real-World Clinical Utility Study

Joos Berghausen, Joe Abdo · 2025

Cancers

Graphene-based biosensors for PSA

Siddig Ibrahim Abdelwahab, Manal Mohamed Elhassan Taha · 2025

Clinica Chimica Acta

pH-Responsive Gold Nanoparticle/PVP Nanoconjugate for Targeted Delivery and Enhanced Anticancer Activity of Withaferin A

Velmurugan Sekar, Amutha Santhanam · 2025

Processes

Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments

Trevor K. Wilson, Oliver T. Zishiri · 2024

Cancer Reports

Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance

Dexin Xu, Wenhai Wang · 2024

Non-coding RNA Research

Astragaloside Ⅳ mediates the effect and mechanism of KPNB1 on biological behavior and tumor growth in prostate cancer

Quan Ma, Xiaojun Lu · 2024

Heliyon

Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer

Vikas Yadav, Manoj Kumar Jena · 2024

Experimental Cell Research

Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential

Sara Anjum Niinuma, Aiman D. Khudair · 2024

Applied Materials Today

The LAT1 inhibitor JPH203 suppresses the growth of castration‐resistant prostate cancer through a CD24‐mediated mechanism

Shinpei Saito, Keisuke Ando · 2024

Cancer Science

Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer

Pasquale Marino, Mariangela Mininni · 2024

Nutrients

Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer

Davide Moi, Davide Bonanni · 2023

European Journal of Medicinal Chemi...

RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells

Fatemeh Khosravani, Fatemeh Amiri · 2023

Archiv für Experimentelle Pathologi...

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

John T. Wei, Daniel Barocas · 2023

Journal of Urology

Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models

Se Hyo Jeong, Min Young Park · 2023

International Journal of Molecular...

Automatic diagnosis and grading of Prostate Cancer with weakly supervised learning on whole slide images

Jinxi Xiang, Xinran Wang · 2023

Computers in Biology and Medicine

Ursolic Acid against Prostate and Urogenital Cancers: A Review of In Vitro and In Vivo Studies

Amanda Kornel, Matteo Nadile · 2023

International Journal of Molecular...

The Association of Prostate Cancer and Urinary Tract Infections: A New Perspective of Prostate Cancer Pathogenesis

Szu-Ying Pan, Wen-Chi Chen · 2023

Medicina

Metrics

2,285

Citations

0

References

Details

Published: Jan 01, 2019
Vol/Issue: 10(2)
Pages: 63-89

Authors

P

Prashanth Rawla

Department of Medicine, Sovah Health, Martinsville, VA 24112, USA

Cite This Article

Prashanth Rawla (2019). Epidemiology of Prostate Cancer. World Journal of Oncology, 10(2), 63-89. https://doi.org/10.14740/wjon1191

Epidemiology of Prostate Cancer

You May Also Like